Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Total Liabilities (2016 - 2025)

Apyx Medical (APYX) has disclosed Total Liabilities for 16 consecutive years, with $52.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities rose 2.97% year-over-year to $52.0 million, compared with a TTM value of $52.0 million through Dec 2025, up 2.97%, and an annual FY2025 reading of $52.0 million, up 2.97% over the prior year.
  • Total Liabilities was $52.0 million for Q4 2025 at Apyx Medical, up from $51.3 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $52.3 million in Q4 2023 and bottomed at $10.9 million in Q1 2021.
  • Average Total Liabilities over 5 years is $31.6 million, with a median of $25.8 million recorded in 2023.
  • The sharpest move saw Total Liabilities fell 6.49% in 2021, then soared 274.18% in 2023.
  • Year by year, Total Liabilities stood at $14.7 million in 2021, then fell by 4.96% to $14.0 million in 2022, then skyrocketed by 274.18% to $52.3 million in 2023, then dropped by 3.46% to $50.5 million in 2024, then grew by 2.97% to $52.0 million in 2025.
  • Business Quant data shows Total Liabilities for APYX at $52.0 million in Q4 2025, $51.3 million in Q3 2025, and $50.7 million in Q2 2025.